Beryl Drugs Share Price
BSE: 524606 | Pharmaceuticals | Small Cap
Beryl Drugs Annualised Returns
Beryl Drugs Annualised Returns
Beryl Drugs Share Price Today
Beryl Drugs Share Price Today
As of 22 Oct 2026, Beryl Drugs share price is ₹25. The stock opened at ₹27.9 and had closed at ₹24.8 the previous day. During today’s trading session, Beryl Drugs share price moved between ₹23.10 and ₹27.90, with an average price for the day of ₹25.50. Over the last 52 weeks, the stock has recorded a low of ₹15.92 and a high of ₹27.90. In terms of performance, Beryl Drugs share price has increased by 3.2% over the past six months and has increased by 10.81% over the last year.
Beryl Drugs Stock Performance
Beryl Drugs Share Price Chart
Beryl Drugs Share Price Chart
Beryl Drugs Company background
Beryl Drugs Limited was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V. fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERICEF injection, FNeuron, Amplocillin INJ, PMol, Biprox, BFlox and many more.The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products.
Beryl Drugs Financial Highlights
For Q4 FY2017–2018, Beryl Drugs's revenue reached ₹4.73 crore and profit touched at ₹0.88 crore. As of 22 October 2026, Beryl Drugs’s market capitalization reached at ₹12.66 crores. Shareholding as of 22 October 2026 shows promoters holding 28% and public at 72%.
Beryl Drugs Fundamental
Market Cap (in crs)
12.66
Face Value
10
Turnover (in lacs)
0.31
Key Metrics
Beryl Drugs Key Financials
View moreBeryl Drugs Technical Analysis
Delivery & Volume
Delivery Volume %
Day
75.20%
Week
78.40%
Month
75.20%
Resistance & Support
Beryl Drugs Peer comparison
CompareIndex Name | Market Price |
|---|---|
13.53 -0.89 (-6.17%)▼ | |
24.96 +0.12 (+0.48%)▲ | |
14.30 -0.13 (-0.90%)▼ | |
4.19 -0.08 (-1.87%)▼ | |
29.62 -1.55 (-4.97%)▼ | |
15.20 -0.80 (-5.00%)▼ | |
4.05 -0.01 (-0.25%)▼ |
Beryl Drugs Latest News
Beryl Drugs Share Price FAQs
You can easily buy Beryl Drugs shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Beryl Drugs share price is ₹27.9 and ₹15.92 as of 21/10/2026.
Please be aware that Beryl Drugs stock prices are subject to continuous fluctuations due to various factors.